274 related articles for article (PubMed ID: 18066623)
21. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
McDaid C; Griffin S; Weatherly H; Durée K; van der Burgt M; van Hout S; Akers J; Davies RJ; Sculpher M; Westwood M
Health Technol Assess; 2009 Jan; 13(4):iii-iv, xi-xiv, 1-119, 143-274. PubMed ID: 19103134
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of CPAP treatment related to cardiovascular disease in patients with severe OSAS: the Greek experience.
Mermigkis C; Bouloukaki I; Schiza SE
Sleep Breath; 2015 May; 19(2):737-9. PubMed ID: 25304123
[No Abstract] [Full Text] [Related]
23. Cost-effectiveness of Continuous Positive Airway Pressure Treatment in Moderate-Severe Obstructive Sleep Apnea Syndrome.
Català R; Villoro R; Merino M; Sangenís S; Colomés L; Hernández Flix S; Pérez de Llano LA
Arch Bronconeumol; 2016 Sep; 52(9):461-9. PubMed ID: 26993090
[TBL] [Abstract][Full Text] [Related]
24. The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea.
Léger D; Stepnowsky C
Sleep Med Rev; 2020 Jun; 51():101275. PubMed ID: 32169792
[TBL] [Abstract][Full Text] [Related]
25. Reducing the cost of treating obstructive sleep apnea: good news for patients.
Stradling JR
Am J Respir Crit Care Med; 2004 Dec; 170(11):1143-4. PubMed ID: 15563640
[No Abstract] [Full Text] [Related]
26. [Factors determining the decision to initiate nCPAP therapy in patients with obstructive sleep apnea (OSA)].
Byśkiniewicz K
Pneumonol Alergol Pol; 2006; 74(1):45-50. PubMed ID: 17175975
[TBL] [Abstract][Full Text] [Related]
27. Characterizing Decisional Conflict in Patients Presenting to Sleep Surgery Clinic and an Exploration of Resource Limitations.
Gulati A; Stephens EM; Cai Y; Chang JL
Laryngoscope; 2021 Oct; 131(10):2384-2390. PubMed ID: 34152601
[TBL] [Abstract][Full Text] [Related]
28. Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea: Maximizing Adherence Including Using Novel Information Technology-based Systems.
Hevener B; Hevener W
Sleep Med Clin; 2016 Sep; 11(3):323-9. PubMed ID: 27542878
[TBL] [Abstract][Full Text] [Related]
29. Latest advances in sleep medicine: obstructive sleep apnea.
Simon S; Collop N
Chest; 2012 Dec; 142(6):1645-1651. PubMed ID: 23208337
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
Ayas NT; FitzGerald JM; Fleetham JA; White DP; Schulzer M; Ryan CF; Ghaeli R; Mercer GW; Cooper P; Tan MC; Marra CA
Arch Intern Med; 2006 May; 166(9):977-84. PubMed ID: 16682570
[TBL] [Abstract][Full Text] [Related]
31. Health Care Savings: The Economic Value of Diagnostic and Therapeutic Care for Obstructive Sleep Apnea.
Watson NF
J Clin Sleep Med; 2016 Aug; 12(8):1075-7. PubMed ID: 27448424
[TBL] [Abstract][Full Text] [Related]
32. Financial Analysis of an Intensive Pediatric Continuous Positive Airway Pressure Program.
Riley EB; Fieldston ES; Xanthopoulos MS; Beck SE; Menello MK; Matthews E; Marcus CL
Sleep; 2017 Feb; 40(2):. PubMed ID: 28364508
[TBL] [Abstract][Full Text] [Related]
33. Estimated cost of crashes in commercial drivers supports screening and treatment of obstructive sleep apnea.
Gurubhagavatula I; Nkwuo JE; Maislin G; Pack AI
Accid Anal Prev; 2008 Jan; 40(1):104-15. PubMed ID: 18215538
[TBL] [Abstract][Full Text] [Related]
34. The economic burden of medical care in general and sleep apnea syndrome in particular.
Krishnan V
Sleep Breath; 2009 Nov; 13(4):315-6. PubMed ID: 19484282
[No Abstract] [Full Text] [Related]
35. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK.
Guest JF; Helter MT; Morga A; Stradling JR
Thorax; 2008 Oct; 63(10):860-5. PubMed ID: 18408048
[TBL] [Abstract][Full Text] [Related]
36. Obstructive sleep apnea: personal, societal, public health, and legal implications.
Morsy NE; Farrag NS; Zaki NFW; Badawy AY; Abdelhafez SA; El-Gilany AH; El Shafey MM; Pandi-Perumal SR; Spence DW; BaHammam AS
Rev Environ Health; 2019 Jun; 34(2):153-169. PubMed ID: 31085749
[TBL] [Abstract][Full Text] [Related]
37. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome.
Weatherly HL; Griffin SC; Mc Daid C; Durée KH; Davies RJ; Stradling JR; Westwood ME; Sculpher MJ
Int J Technol Assess Health Care; 2009 Jan; 25(1):26-34. PubMed ID: 19126248
[TBL] [Abstract][Full Text] [Related]
38. Continuous positive airway pressure titration for obstructive sleep apnoea: automatic versus manual titration.
McArdle N; Singh B; Murphy M; Gain KR; Maguire C; Mutch S; Hillman DR
Thorax; 2010 Jul; 65(7):606-11. PubMed ID: 20627917
[TBL] [Abstract][Full Text] [Related]
39. The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis.
Borsoi L; Armeni P; Donin G; Costa F; Ferini-Strambi L
PLoS One; 2022; 17(5):e0268677. PubMed ID: 35594257
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive management of obstructive sleep apnea by telemedicine: Clinical improvement and cost-effectiveness of a Virtual Sleep Unit. A randomized controlled trial.
Lugo VM; Garmendia O; Suarez-Girón M; Torres M; Vázquez-Polo FJ; Negrín MA; Moraleda A; Roman M; Puig M; Ruiz C; Egea C; Masa JF; Farré R; Montserrat JM
PLoS One; 2019; 14(10):e0224069. PubMed ID: 31647838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
